Medication info

Terbinafine Tablets (Terbinafine Hydrochloride)

Prescription medicationTabletExpired
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Ahn-Guk New Pharm Co., Ltd.
Appearance
White round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201903418 · Approved 2019.05.27

This product's status changed to Expired on 2024.05.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of onychomycosis, cutaneous fungal infections (e.g., tinea pedis and tinea corporis), and tinea capitis
Who uses it
Adults · Children
Adult dosage
Administer 125 mg twice daily or 250 mg once daily. The duration of treatment according to the disease is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. The treatment period may be shortened to 3 months or less in patients with infection of a fingernail or a relatively small toenail, or in younger patients. A 3-month treatment period is usually sufficient for toenail infections, but some patients may require 6 months or longer. The treatment period may be longer in patients with slow toenail growth. Reduce the daily dose by 1/2 in patients with creatinine clearance below 50 mL per minute.
Children's dosage
Children: Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks 1) Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. Because experience with administration is limited, the decision to treat should be based on consideration of the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg once daily.

Ingredients

Manufacturer
Ahn-Guk New Pharm Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, cutaneous fungal infections (e.g., tinea pedis and tinea corporis), and tinea capitis

  • Dermatophytosis
  • tinea pedis
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medication is used to treat tinea pedis, tinea corporis, tinea cruris, and onychomycosis caused by dermatophytes in adults, as well as tinea capitis in children.

Dosage and Administration

Adult dosage

Administer 125 mg twice daily or 250 mg once daily. The duration of treatment according to the disease is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. The treatment period may be shortened to 3 months or less in patients with infection of a fingernail or a relatively small toenail, or in younger patients. A 3-month treatment period is usually sufficient for toenail infections, but some patients may require 6 months or longer. The treatment period may be longer in patients with slow toenail growth. Reduce the daily dose by 1/2 in patients with creatinine clearance below 50 mL per minute.

Children's dosage

Children: Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks 1) Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. Because experience with administration is limited, the decision to treat should be based on consideration of the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg once daily.

Precautions

This drug is not recommended for patients with liver health issues or a history of liver disease. Liver function tests must be performed before administration, and regular liver function tests should be conducted during treatment. If symptoms of liver dysfunction appear, discontinue use of this medication immediately and consult a doctor. This drug should not be used in patients with blood disorders or severe renal impairment, children under 2 years of age, or breastfeeding women. Also, patients who have had allergic reactions to this drug should avoid its use. Caution should be exercised when administering to elderly patients, those with renal insufficiency, or young children with low body weight. Immediate discontinuation of use is necessary if serious skin reactions occur. This medication can cause various adverse reactions, so if symptoms such as rash, itching, nausea, fatigue, myalgia, headache, visual disturbances occur, notify a healthcare professional immediately. Be cautious while driving or operating machinery, as symptoms such as dizziness may occur. Interactions may occur when taken with other medications, so if you are taking other drugs, it is essential to inform your doctor or pharmacist, and dosage adjustments may be necessary. Women who are pregnant or may become pregnant should carefully consider the risks and benefits before taking this medication. Breastfeeding women should discontinue breastfeeding while taking this drug. Overdose may cause headaches, nausea, abdominal pain, and dizziness, requiring immediate medical treatment. This medication should be stored out of the reach of children and kept away from direct sunlight at room temperature.

Side effects

Liver failure, hepatitis, bile duct obstruction, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, fatigue, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasis-like rash, worsening of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, elevated serum myoglobin, elevated urine myoglobin, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, reduced appetite, dyspepsia, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, vomiting, glossitis, depression, anxiety, headache, loss of taste, taste disorder, dizziness, drowsiness, paresthesia, sensory loss, reduced attention, insomnia, elevated BUN, pollakiuria, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol, elevated triglycerides, fatigue, discoloration of the tongue, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, reduced vision, hearing loss, auditory impairment, vasculitis, permanent hyposmia, anosmia, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally in a temperature range of 1 to 30 degrees Celsius. Storing this way ensures the medication's efficacy is maintained and prevents degradation.

Appearance and packaging

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.